Advertisement

Breast Cancer Research and Treatment

, Volume 7, Issue 3, pp 201–210 | Cite as

Immunological detection and quantitation of alpha transforming growth factors in human breast carcinoma cells

  • Isabelle Perroteau
  • David Salomon
  • Michele DeBortoli
  • William Kidwell
  • Parule Hazarika
  • Robert Pardue
  • John Dedman
  • James Tam
Report

Summary

Alpha transforming growth factors (αTGFs) were immunologically detected in the concentrated conditioned medium (CM) prepared from four human breast cancer cell lines and from primary cultures of human mammary epithelial cells, and in the tissue extracts prepared from normal, benign, and malignant breast biopsies. Immunoreactive αTGFs were quantitated by a competitive radioimmunoassay (RIA) using affinity-purified polyclonal sheep anti-rat αTGF antibodies which react with human αTGF but not with human epidermal growth factor (EGF). The relative level of RIA-detectable αTGFs in the CM from the breast cancer cell lines MCF-7, ZR-75-1, T47-D, and MDA-MB-231, and from the CM of primary cultures of human mammary epithelial cells, ranged from 0.02 to 0.85 ng/ml. MCF-7 or ZR-75-1 cells grown in the presence of 17β-estradiol (10−8 M) for 48 h were found to release two- to three-fold more αTGFs into their CM than the same cells grown in the absence of estrogen. In detergent extracts prepared from normal breast tissue, a benign fibrocystic lesion, fibroadenomas and primary breast carcinomas, the relative αTGF concentrations were found to range from 1.5 to 6 ng/mg cell protein. No significant correlations were found between the αTGF levels and the pathological state of the tissues, the estrogen receptor status of the tumors, or the relative amounts of theras gene protein p21ras in the tissues as determined by Western immunoblot analysis. The question of biological relevancy of αTGF for human mammary tumors will require further studies on (a) synthesis and turnover of αTGF, (b) the relationship between immunoreactivity and biological activity of αTGF, and (c) differences in biological responsiveness of mammary tumor cells.

keywords

αTGFs breast cancer cells estrogen estrogen receptor p21ras protein radioimmunoassay 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Brown KD, Blakeley DM: Transforming growth factors: sources, properties and possible roles in normal and malignant cell growth control. Biochem Soc Trans 12: 168–173, 1984PubMedGoogle Scholar
  2. 2.
    Massague J: The transforming growth factors. Trends in Biochem Sci, June: 237–240, 1985Google Scholar
  3. 3.
    Moses HL: Growth factors and transforming growth factors: potential roles in cancer. Proc Am Assoc Cancer Res, 412–413, 1984Google Scholar
  4. 4.
    Heldin CH, Westermark B: Growth factors: mechanism of action and relation to oncogenes. Cell 37: 9–20, 1984PubMedGoogle Scholar
  5. 5.
    Sporn MB, Roberts AB: Autocrine growth factors and cancer. Nature 313: 745–747, 1985PubMedGoogle Scholar
  6. 6.
    Marquardt H, Hunkapiller MW, Hood LE, Todaro GJ: Rat transforming growth factor type 1: structure and relation to epidermal growth factor. Science 223: 1079–1082m, 1984PubMedGoogle Scholar
  7. 7.
    Derynck R, Roberts AB, Winkler ME, Chen EY, Goeddel DV: Human transforming growth factor-α: precursor structure and expression in E. coli. Cell 38: 287–297, 1984Google Scholar
  8. 8.
    Linsley PS, Hargreaves WR, Twardzik DR, Todaro GJ: Detection of larger polypeptides structurally and functionally related to type 1 transforming growth factor. Proc Natl Acad Sci USA 82: 356–360, 1985PubMedGoogle Scholar
  9. 9.
    Hazaraki P, Dedman JR, Lorenzo I, Sarvada T, Earls R, Pardue RL: Detection and quantitation of alpha transforming growth factor using antibodies to synthetic polypeptides. J Biol Chem, 1986, in pressGoogle Scholar
  10. 10.
    Assoian RK, Grotendorst GR, Miller DM, Sporn MB: Cellular transformation by coordinated action of three peptide growth factors from human platelets. Nature 309: 804–806, 1984PubMedGoogle Scholar
  11. 11.
    Nickell KA, Halper J, Moses HL: Transforming growth factor in solid human malignant neoplasms. Cancer Res 43: 1966–1971, 1983PubMedGoogle Scholar
  12. 12.
    Salomon DS, Zwiebel JA, Bano M, Losanczy I, Fehnel P, Kidwell WR: Presence of transforming growth factors in human breast cancer cells. Cancer Res 44: 4069–4077, 1984PubMedGoogle Scholar
  13. 13.
    Hamburger AW, White CP, Dunn FE: Secretion of trans-forming growth factors by primary human tumor cells. Br J Cancer 51: 9–14, 1985PubMedGoogle Scholar
  14. 14.
    Bates SE, Lippman ME, Dickson RB: Production of transforming growth factors by human breast cancer cell lines (Abstract no. 778). Proc Am Assoc Cancer Res 26: 197, 1985Google Scholar
  15. 15.
    Bates SE, McManaway M, Dickson RB: Transforming growth factors in human breast cancer (Abstract). Endocrine Soc Absts 444, 1985Google Scholar
  16. 16.
    Zwiebel JA, Bano M, Nexo E, Salomon DS, Kidwell WR: Partial purification of transforming growth factors from human milk. Cancer Res 46: 933–939, 1986PubMedGoogle Scholar
  17. 17.
    Kidwell WR, Bano M, Salomon DS: Growth of normal mammary epithelium on collagen in serum-free medium. In: Barnes DM, Sirbasku DA, Sato GH (eds): Cell Culture Methods for Molecular and Cell Biology, Vol 2. Methods for Serum-Free Culture of Cells of the Endocrine System. Alan R. Liss, Inc., New York, 1984, pp 105–125Google Scholar
  18. 18.
    DeBortoli ME, Abou-Issa H, Haley BE, Cho-Chung YS: Amplified expression of p21ras protein in hormone-depen-dent mammary carcinomas of humans and rodents. Biochem Biophys Res Commun 127: 699–706, 1985PubMedGoogle Scholar
  19. 19.
    Tam JP, Marquardt H, Rosberger DF, Wong RW, Todaro GJ: Synthesis of biologically active rat transforming growth factor I. Nature 309: 376–378, 1984PubMedGoogle Scholar
  20. 20.
    Schaudies PR, Savage JR: Isolation of rat EGF: chemical, biological and immunological comparison with mouse and human EGF. Comp Biochem Biophys, 1986, in pressGoogle Scholar
  21. 21.
    Hand PH, Thor A, Wunderlich D, Caruso A, Schlom JE: Monoclonal antibodies of predefined specificity detect activatedras gene expression in human mammary and colon carcinomas. Proc Natl Acad Sci USA 81: 5227–5231, 1984PubMedGoogle Scholar
  22. 22.
    Lippman ME: Definition of hormones and growth factors required for optimal proliferation and expression of phenotypic responses in human breast cancer cells. In: Barnes DM, Sirbasku DA, Sato GH (eds): Cell Culture Methods for Molecular and Cell Biology, Vol 2. Methods for Serum-Free Culture of Cells of the Endocrine System. Alan R. Liss, Inc., New York, 1984, pp 183–200Google Scholar
  23. 23.
    Sainsbury JRC, Hirst EA, Needham GK, Farndon JR, Harris AL: Fibroblast cell lines derived from human breast cancers have epidermal growth factor receptors and produce an epidermal growth factor like molecule (Abstract). Br J Cancer 52: 440, 1985Google Scholar
  24. 24.
    Kurobe M, Furukawa S, Hayashi K: Synthesis and secretion of an epidermal growth factor (EGF) by human fibroblast cells in culture. Biochem Biophys Res Commun 131: 1080–1085, 1985PubMedGoogle Scholar
  25. 25.
    Derynck R, Roberts AB, Eaton DH, Winkler ME, Goeddel DV: Human transforming growth factor-α: precursor sequence, gene structure and heterologous expression. In: Feramisco JA, Ozanne B, Stiles CA (eds): Growth Factors and Transformation, Vol III. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 1985, pp 79–86Google Scholar
  26. 26.
    Fitzpatrick SL, Brightwell J, Witliff JI, Barrows GA, Schultz GS: Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progesterone receptor levels. Cancer Res 44: 3448–3453, 1984PubMedGoogle Scholar
  27. 27.
    Perez R, Pascual M, Macias A, Lage A: Epidermal growth factor receptors in human breast cancer. Breast Cancer Res Treat 4: 189–193, 1984PubMedGoogle Scholar
  28. 28.
    Sainsbury JRC, Sherbert GV, Farndon JR, Harris AL: Epidermal growth factor receptors and oestrogen receptors in human breast cancer. Lancet i: 364–366, 1985Google Scholar
  29. 29.
    Sainsbury JRC, Farndon JR, Harris AL, Sherbert GV: Epidermal growth factor receptors on human breast cancers. Br J Surg 72: 186–188, 1985PubMedGoogle Scholar
  30. 30.
    Hirst EA, Sainsbury JRC, Harris AL: Epidermal growth factors and oestrogen receptors in human breast cancers — is there a link? (Abstract) Br J Cancer 52: 441, 1985Google Scholar
  31. 31.
    Kidwell WR, Salomon DS, Liotta LA, Zwiebel JA, Bano M: Effects of growth factors on mammary epithelial cell proliferation and basement membrane synthesis. In: Sato GH, Pardee AR, Sirbasku DA (eds): Growth of Cells in Hormonally Defined Media, Book B, Cold Spring Harbor Conferences on Cell Proliferation, Vol 9. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 1982, pp 807–818Google Scholar
  32. 32.
    Zwiebel JA, Davis MR, Kohn E, Salomon DS, Kidwell WR: Anchorage-independent growth-conferring factor production by rat mammary tumor cells. Cancer Res 42: 5117–5125, 1982PubMedGoogle Scholar
  33. 33.
    Kimball ES, Bohn WH, Cockley KD, Warren TC, Sherwin S: Distinct high performance liquid chromatography pattern of transforming growth factor activity in the urine of cancer patients as compared to that of normal individuals. Cancer Res 44: 3613–3619, 1984PubMedGoogle Scholar
  34. 34.
    Salomon DS, Kidwell WR, Smith G, Bell GI: Presence of alpha transforming growth factors (αTGFs) in human breast tumors and human milk (Abstract No. 785). Proc Am Assoc Cancer Res 26: 198, 1985Google Scholar
  35. 35.
    Twardzik DR: Differential expression of transforming growth factor-α during prenatal development of the mouse. Cancer Res 45: 5413–5416, 1985PubMedGoogle Scholar

Copyright information

© Martinus Nijhoff Publishers 1986

Authors and Affiliations

  • Isabelle Perroteau
    • 1
  • David Salomon
    • 1
  • Michele DeBortoli
    • 1
  • William Kidwell
    • 1
  • Parule Hazarika
    • 2
  • Robert Pardue
    • 2
  • John Dedman
    • 2
  • James Tam
    • 3
  1. 1.Laboratory of Tumor Immunology and BiologyNational Cancer Institute, National Institutes of HealthBethesdaUSA
  2. 2.Departments of Cell Biology and Physiology and Internal MedicineUniversity of Texas Health Science CenterHoustonUSA
  3. 3.Department of BiochemistryRockefeller UniversityNew YorkUSA

Personalised recommendations